Families often notice the first signs slowly. Forgotten appointments, repeated questions, or names that suddenly disappear from memory.
Alzheimer’s remains one of the world’s biggest medical challenges, with researchers still searching for treatments that can truly slow the disease.
Now, a new study from the Institute for Bioengineering of Catalonia (IBEC), West China Hospital Sichuan University, and researchers in the UK points to a possible new direction, reports Science Daily.
Focus on the brain’s filter
Instead of concentrating only on damaged brain cells, the researchers examined the blood-brain barrier — the system responsible for protecting the brain and clearing waste products.
The team developed specially engineered nanoparticles designed to help the brain remove amyloid-beta, a protein closely linked to Alzheimer’s disease.
The experiments were carried out on genetically modified mice that develop symptoms similar to Alzheimer’s in humans.
Rapid results
According to the researchers, amyloid-beta levels dropped significantly shortly after treatment.
Over time, the mice also performed better in memory and behavioral tests compared with untreated animals.
Scientists believe the therapy may have helped restore parts of the brain’s natural waste-clearing system while improving blood vessel function around the brain.
Still early research
Researchers stress that positive results in mice do not guarantee success in humans. Many previous Alzheimer’s treatments have shown promise in animal studies before failing in clinical trials.
Still, the study adds weight to a growing theory that Alzheimer’s may be connected not only to nerve cell damage, but also to changes in the brain’s blood vessels and its ability to remove harmful waste.
